WHO/CDS/HIV/18.5 Demographic and socioeconomic data Eswatini HIV Country Pro le: 217 1.4 million Total population (217) 8 52 US$ GNI per capita, PPP (217) World Bank 389 Maternal mortality per 1 live births (215) World Health Stat., WHO % Health expenditure, total (% of GDP) (215) World Bank 55 years Life expectancy at birth (215) 248 US$ Health expenditure per capita (214) World Bank 3.3 Total fertility rate (births per woman) (215) Human Development Index Value (217) 64% 8% Estimated ART coverage children and adults 95% Estimated % of pregnant women living with HIV who received ARVs for PMTCT http://cfs.hivci.org/country-factsheet.html# 1/6
9-9-9 progress towards 22 targets 1% 75% 9 % 85 % 74 % 5% 25% % PLHIV who know their status PLHIV receiving ART PLHIV with viral load suppression Health sector cascade Value Percent of 9-9-9 People who know their status 185 9% Reported number of people receiving ART 174 85% People with viral load suppression 151 74% Estimated number of people newly infected with HIV 175 Estimated number of people newly infected with HIV 15 125 1 75 5 25 21 211 212 213 214 215 216 217 http://cfs.hivci.org/country-factsheet.html# 2/6
Estimated number of deaths due to AIDS 6 5 Estimated number of deaths due to AIDS 4 3 2 1 21 211 212 213 214 215 216 217 Epidemiological HIV data Value Estimated number of people living with HIV 21 Estimated number of children aged to 14 living with HIV 13 Estimated number of women (15+) living with HIV 12 Estimated adult (15-49) prevalence 27.4% Estimated number of deaths due to HIV 3 5 Estimated number of people newly infected with HIV 7 Estimated incidence rate per 1 uninfected population 8.2 Antiretroviral therapy (ART) Reported number of people receiving ART 174 Estimated ART coverage 85% Reported number of adults receiving ART 164 Estimated ART coverage (adults, 15+) 86% Reported number of children receiving ART 9 9 http://cfs.hivci.org/country-factsheet.html# 3/6
Antiretroviral therapy (ART) Estimated ART coverage (children, -14) 75% Prevention of mother-to-child transmission (PMTCT) Value Year Reported number of pregnant women living with HIV who received antiretrovirals for PMTCT 1 4 217 Estimated percentage of pregnant women living with HIV who received antiretrovirals for PMTCT* 2 95% 217 3 Transmission rate including breastfeeding period* 6 217 Antenatal care coverage - at least one visit (%) 99% 214 Antenatal care coverage - at least four visits (%) 76% 29 % of pregnant women with known HIV status Antenatal care attendees who were tested for syphilis (%) 85% 216 Antenatal care attendees who tested positive for syphilis (%) 2.4% 216 Antenatal care attendees who tested positive for syphilis and who received benzathine penicillin IM (%) % of infants born to women living with HIV receiving a virological test within two months of birth (EID)* 1 9% 216 78% 216 * Tracing indicators for elimination of monther-to-child transmission. A color scheme (green, orange,red) is used to indicate if the country is on target to meet 22 targets: 19% 295% 3Less than 5 Key populations Percentage condom use among sex workers with most recent client 83% Needles distributed per person who inject drugs per year HIV prevalence among men who have sex with men (%) 13% HIV prevalence among sex workers (%) 61% HIV prevalence among people who inject drugs (%) Percentage of people who inject drugs receiving OST Median annual price of ARV drug regimens for adults http://cfs.hivci.org/country-factsheet.html# 4/6
25 First line Median price in US dollars per person per year 2 15 1 5 21 211 212 213 214 215 216 [TDF+3TC+EFV] [6+3+3]mg [TDF+FTC+EFV] [6+2+3]mg [ZDV+3TC+NVP] [15+2+3]mg Median price in US dollars per person per year 6 4 2 Second line 21 211 212 213 214 215 216 [TDF+3TC]+[ATV/r] [TDF+3TC]+[LPV/r] [TDF+FTC]+[LPV/r] [ZDV+3TC]+[ATV/r] [ZDV+3TC]+[LPV/r] National HIV policies and plans Implementation of national policy on HIV selftesting (HIVST) Treatment initiation threshold adults and adolescents Policy on HIVST implemented Treat all regardless of CD4 count http://cfs.hivci.org/country-factsheet.html# 5/6
National HIV policies and plans Treatment initiation threshold children Treat all, regardless of age Implementation of treat all adults and adolescents Implemented countrywide Dolutegravir (DTG) as part of 1st line ARVs for adults and adolescents Implementation of lifelong ART to pregnant & breastfeeding women Implementation of national policy on viral load monitoring DTG introduced in national guidelines Implemented countrywide Fully implemented Completion of HIV services cascades Not completed a national HIV cascade Adaptation of who key population guidelines in national plans Adapted to national policy or plans National M&E plan or strategy for HIV Yes, but not updated in the past two years Method to de-duplicate key data (i.e. unique identi ers) Nationally representative quality assessment of facility-level ART data Yes Yes WHO 218. Some rights reserved. Licence CC BY-NC-SA 3. IGO http://cfs.hivci.org/country-factsheet.html# 6/6